236 related articles for article (PubMed ID: 29496022)
1. Clinical Characteristics and Outcome of Methamphetamine-Associated Pulmonary Arterial Hypertension and Dilated Cardiomyopathy.
Zhao SX; Kwong C; Swaminathan A; Gohil A; Crawford MH
JACC Heart Fail; 2018 Mar; 6(3):209-218. PubMed ID: 29496022
[TBL] [Abstract][Full Text] [Related]
2. Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.
Zamanian RT; Hedlin H; Greuenwald P; Wilson DM; Segal JI; Jorden M; Kudelko K; Liu J; Hsi A; Rupp A; Sweatt AJ; Tuder R; Berry GJ; Rabinovitch M; Doyle RL; de Jesus Perez V; Kawut SM
Am J Respir Crit Care Med; 2018 Mar; 197(6):788-800. PubMed ID: 28934596
[TBL] [Abstract][Full Text] [Related]
3. Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension.
Charoenpong P; Hall NM; Keller CM; Ram AK; Murnane KS; Goeders NE; Dhillon NK; Walter RE
Chest; 2024 Jun; 165(6):1518-1533. PubMed ID: 38211700
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
Sutter ME; Gaedigk A; Albertson TE; Southard J; Owen KP; Mills LD; Diercks DB
Clin Toxicol (Phila); 2013 Aug; 51(7):540-4. PubMed ID: 23855716
[TBL] [Abstract][Full Text] [Related]
5. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?
Chin KM; Channick RN; Rubin LJ
Chest; 2006 Dec; 130(6):1657-63. PubMed ID: 17166979
[TBL] [Abstract][Full Text] [Related]
6. Sex Differences in Methamphetamine Use and Dependence in a Thai Treatment Center.
Rungnirundorn T; Verachai V; Gelernter J; Malison RT; Kalayasiri R
J Addict Med; 2017; 11(1):19-27. PubMed ID: 27649265
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics, Histopathological Features, and Clinical Outcome of Methamphetamine-Associated Cardiomyopathy.
Schürer S; Klingel K; Sandri M; Majunke N; Besler C; Kandolf R; Lurz P; Luck M; Hertel P; Schuler G; Linke A; Mangner N
JACC Heart Fail; 2017 Jun; 5(6):435-445. PubMed ID: 28571597
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary arterial hypertension seen in methamphetamine abusers.
Thompson CA
Am J Health Syst Pharm; 2008 Jun; 65(12):1109-10. PubMed ID: 18541676
[No Abstract] [Full Text] [Related]
9. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand.
Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M
BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802
[TBL] [Abstract][Full Text] [Related]
10. Screening Of Pulmonary Hypertension in Methamphetamine Abusers (SOPHMA): rationale and design of a multicentre, cross-sectional study.
Cheng Y; Tung CK; Chung AKK; Liu WW; Huang D; Chan PH; Lam M; Chan WC; Siu CW; Hai JJ
BMJ Open; 2019 Aug; 9(8):e027193. PubMed ID: 31375608
[TBL] [Abstract][Full Text] [Related]
11. Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank).
Charoenpong P; Dhillon N; Murnane K; Goeders N; Hall N; Keller C; Bhuiyan MAN; Walter R
BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38061804
[TBL] [Abstract][Full Text] [Related]
12. Sex-dependent right ventricular hypertrophic gene changes after methamphetamine treatment in mice.
Labazi H; Nilsen M; MacLean MR
Eur J Pharmacol; 2021 Jun; 900():174066. PubMed ID: 33789156
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Clinical Characteristics and Outcomes of Patients With Reversible Versus Persistent Methamphetamine-Associated Cardiomyopathy.
Zhao SX; Seng S; Deluna A; Yu EC; Crawford MH
Am J Cardiol; 2020 Jan; 125(1):127-134. PubMed ID: 31699360
[TBL] [Abstract][Full Text] [Related]
14. A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse.
Ito H; Yeo KK; Wijetunga M; Seto TB; Tay K; Schatz IJ
Clin Cardiol; 2009 Jun; 32(6):E18-22. PubMed ID: 19330818
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effect of methamphetamine on traumatic injury complications and outcomes.
Neeki MM; Dong F; Liang L; Toy J; Carrico B; Jabourian N; Sin A; Hussain F; Brown S; Safdari K; Borger R; Wong D
Addict Sci Clin Pract; 2018 Mar; 13(1):11. PubMed ID: 29592800
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and Outcomes of Methamphetamine Abuse Among Veterans With Heart Failure.
Nishimura M; Ma J; Fox S; Toomu A; Mojaver S; Juang DK; Maisel AS; Thomas IC
Am J Cardiol; 2019 Sep; 124(6):907-911. PubMed ID: 31311659
[TBL] [Abstract][Full Text] [Related]
17. The relationship between methamphetamine use and increased dental disease.
Shetty V; Mooney LJ; Zigler CM; Belin TR; Murphy D; Rawson R
J Am Dent Assoc; 2010 Mar; 141(3):307-18. PubMed ID: 20194387
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical Challenges.
Thoi F; Scherer DJ; Kaye DM; Sanders P; Stokes MB
Heart Lung Circ; 2022 May; 31(5):616-622. PubMed ID: 35153149
[TBL] [Abstract][Full Text] [Related]
19. Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
Kolaitis NA; Zamanian RT; de Jesus Perez VA; Badesch DB; Benza RL; Burger CD; Chakinala MM; Elwing JM; Feldman J; Lammi MR; Mathai SC; McConnell JW; Presberg KW; Robinson JC; Sager J; Shlobin OA; Simon MA; Kawut SM; Glidden DV; Singer JP; De Marco T;
Ann Am Thorac Soc; 2021 Apr; 18(4):613-622. PubMed ID: 33064950
[No Abstract] [Full Text] [Related]
20. Methamphetamine and the risk of pulmonary arterial hypertension.
Ramirez RL; Perez VJ; Zamanian RT
Curr Opin Pulm Med; 2018 Sep; 24(5):416-424. PubMed ID: 30036313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
